8751 - 8800 of 8801 Results
Title
Year
-
RESTRICTEDTitle: The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian ratsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 545Issue #:Start Page: 59End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.04.017Citation Count: 7
-
OPENTitle: Pre-symptomatic Parkinson’s disease blood test quantifying repetitive sequence motifs in transfer RNA fragmentsJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43587-025-00851-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12092246Citation Count: 3
-
OPENTitle: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00604-yBest OA location URL: https://www.nature.com/articles/s41531-023-00604-y.pdfCitation Count: 38
-
OPENTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://mbexc.uni-goettingen.de/literature/publications/904Citation Count: 4
-
OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://escholarship.org/uc/item/6cf8k71wCitation Count: 41
- White Matter Changes Correlates of Peripheral Neuroinflammation in Patients with Parkinson’s Disease2017RESTRICTEDTitle: White Matter Changes Correlates of Peripheral Neuroinflammation in Patients with Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 403Issue #:Start Page: 70End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2017.10.050Citation Count: 33
-
RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
RESTRICTEDTitle: Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case seriesJournal Name: International Journal of Speech-Language PathologyPublisher: Informa UK LimitedVol: 27Issue #: 2Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17549507.2024.2330538Citation Count: 5
-
OPENTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978749Citation Count: 65
-
OPENTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://doi.org/10.1021/acscentsci.8b00879Citation Count: 146
-
RESTRICTEDTitle: Fecal tyrosine decarboxylase and motor response complications in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107947End Page: 107947Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107947Citation Count: 0
-
OPENTitle: Identification of a Putative α-synuclein Radioligand Using an in silico Similarity SearchJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 704End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11307-023-01814-9Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10527666/pdf/nihms-1908506.pdfCitation Count: 9
- Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export2020OPENTitle: Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide exportJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 139Issue #: 6Start Page: 1001End Page: 1024Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-020-02145-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-020-02145-7.pdfCitation Count: 59
-
OPENTitle: Validating Differential Volatilome Profiles in Parkinson’s DiseaseJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 2Start Page: 300End Page: 306Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.0c01028Best OA location URL: https://doi.org/10.1021/acscentsci.0c01028Citation Count: 36
-
OPENTitle: Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson’s DiseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 10Start Page: e0162799End Page: e0162799Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0162799Best OA location URL: https://escholarship.org/uc/item/04f2w50wCitation Count: 102
-
OPENTitle: Pathological α-synuclein perturbs nuclear integrityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 214Issue #:Start Page: 107028End Page: 107028Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107028Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107028Citation Count: 0
-
OPENTitle: The Effect of the COVID-19 Pandemic on People with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1365End Page: 1377Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202249Best OA location URL: https://escholarship.org/uc/item/231295zgCitation Count: 165
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017OPENTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 33
-
OPENTitle: α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controlsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 6Issue #: 12Start Page: 2426End Page: 2436Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.50944Best OA location URL: https://hdl.handle.net/11384/134333Citation Count: 36
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 113
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/f5e24699-93e4-49fc-a6e3-c3d92fd2d0b9Citation Count: 108
-
RESTRICTEDTitle: The PRIPS study: screening battery for subjects at risk for Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 20Issue #: 1Start Page: 102End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2012.03798.xCitation Count: 119
-
RESTRICTEDTitle: The Progressive Supranuclear Palsy Clinical Deficits Scale accurately reflects functional as well as patient- and caregiver-reported outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108060End Page: 108060Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108060Citation Count: 0
- Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease2017RESTRICTEDTitle: Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 101End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.016Citation Count: 20
-
OPENTitle: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00892-7Best OA location URL: https://doi.org/10.1186/s13195-021-00892-7Citation Count: 20
- Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease2018OPENTitle: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 26Issue #: 2Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13797Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6329649Citation Count: 52
- Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease2021OPENTitle: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1451End Page: 1455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28525Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28525Citation Count: 21
-
RESTRICTEDTitle: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 124Issue #:Start Page: 130259End Page: 130259Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259Citation Count: 0
-
OPENTitle: Immunotherapy in Parkinson’s disease: Current status and future directionsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104587End Page: 104587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104587Citation Count: 66
-
RESTRICTEDTitle: Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1392End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25157Citation Count: 131
-
OPENTitle: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligaseJournal Name: AutophagyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2531025Best OA location URL: https://doi.org/10.1080/15548627.2025.2531025Citation Count: 0
-
RESTRICTEDTitle: Structural connectome alterations in prodromal and de novo Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 45Issue #:Start Page: 21End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.09.019Best OA location URL: http://scholarbank.nus.edu.sg/handle/10635/148986Citation Count: 36
-
RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 34
-
OPENTitle: S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body DementiaJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 14Start Page: 3011End Page: 3024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1508-21.2022Best OA location URL: https://escholarship.org/uc/item/0n57v9mfCitation Count: 39
-
OPENTitle: Synapsin III Regulates Dopaminergic Neuron Development in VertebratesJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 23Start Page: 3902End Page: 3902Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11233902Best OA location URL: https://www.mdpi.com/2073-4409/11/23/3902/pdf?version=1669977075Citation Count: 4
-
OPENTitle: Feedforward activation of PRKN/parkinJournal Name: AutophagyPublisher: Informa UK LimitedVol: 19Issue #: 2Start Page: 729End Page: 730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851250Citation Count: 6
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6429430Citation Count: 42
-
OPENTitle: Can Isolated Enlarged Virchow‐Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 67End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12009Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12009Citation Count: 17
-
OPENTitle: Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levelsJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-017-0978-zBest OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-017-0978-zCitation Count: 67
-
RESTRICTEDTitle: No Association Between Rare TWNK Variants and Parkinson's Disease in European CohortsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2318End Page: 2319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29216Citation Count: 4
-
RESTRICTEDTitle: 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated miceJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 92Issue #:Start Page: 86End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2014.11.005Citation Count: 59
-
OPENTitle: Cerebellum mitochondrial DNA copy number is increased in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 4Start Page: fcaf296End Page: fcaf296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf296Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf296/64085391/fcaf296.pdfCitation Count: 0
-
RESTRICTEDTitle: Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neuritesJournal Name: Clinical and Translational ImagingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 3End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40336-016-0217-4Citation Count: 47
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
-
RESTRICTEDTitle: Deep brain stimulation of the substantia nigra for freezing of gait in Parkinson's disease: is it about stimulation frequency?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 229End Page: 230Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.010Citation Count: 14
- Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial2014OPENTitle: Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled TrialJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 348End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12082Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12082Citation Count: 13
- Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease2022OPENTitle: Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00300-3Best OA location URL: https://www.nature.com/articles/s41531-022-00300-3.pdfCitation Count: 27
-
OPENTitle: [3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brainJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 242Issue #: 5Start Page: 1203End Page: 1214Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00221-024-06815-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00221-024-06815-w.pdfCitation Count: 2
-
OPENTitle: Temporal discrimination threshold and blink reflex recovery cycle in cervical dystonia – two sides of the same coin?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 4End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.028Best OA location URL: https://eprints.soton.ac.uk/434837/1/PARKRELDIS_D_19_00249_unmarked.pdfCitation Count: 5
-
RESTRICTEDTitle: A cell culture model for monitoring α-synuclein cell-to-cell transferJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 77Issue #:Start Page: 266End Page: 275Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.07.003Citation Count: 79